Experimental study on fluorescent microspheres as a tracer for sentinel node detection.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 15868914)

Published in Anticancer Res on May 04, 2005

Authors

Hideaki Ueno1, Jun Hihara, Katsuhiko Shimizu, Akihiko Osaki, Yoshinori Yamashita, Kazuhiro Yoshida, Tetsuya Toge

Author Affiliations

1: Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. hihara@hiroshima-u.ac.jp

Articles by these authors

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol (2009) 5.56

Introducing meta-services for biomedical information extraction. Genome Biol (2008) 2.78

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol (2013) 2.45

Transgenic silkworms produce recombinant human type III procollagen in cocoons. Nat Biotechnol (2002) 2.42

Filling the gaps between tools and users: a tool comparator, using protein-protein interaction as an example. Pac Symp Biocomput (2008) 1.75

Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother Pharmacol (2002) 1.69

Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy. Cancer (2004) 1.58

Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Pancreas (2006) 1.53

Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clin Cancer Res (2003) 1.50

A case of benign intraductal papillary mucinous neoplasm of the pancreas containing two major subtypes. J Gastrointestin Liver Dis (2008) 1.43

A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors. Int J Clin Oncol (2005) 1.42

Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer (2009) 1.34

Targeted therapy against Bcl-2-related proteins in breast cancer cells. Breast Cancer Res (2005) 1.27

Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines. Int J Cancer (2006) 1.21

Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer (2006) 1.20

Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START). J Cancer Res Clin Oncol (2013) 1.18

Retracted Aberrant methylation of heparan sulfate glucosamine 3-O-sulfotransferase 2 genes as a biomarker in colorectal cancer. Anticancer Res (2010) 1.18

The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy. Cancer (2004) 1.16

A novel telomerase template antagonist (GRN163) as a potential anticancer agent. Cancer Res (2003) 1.15

Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Sci (2004) 1.13

A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer. Pathobiology (2005) 1.13

Clinicopathological findings of immunoglobulin G4-related kidney disease. Clin Exp Nephrol (2011) 1.12

A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol (2004) 1.10

Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma. Eur J Cancer (2004) 1.10

Cavernous hemangioma of the rib. Ann Thorac Surg (2002) 1.10

Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res (2004) 1.10

N-H insertion reactions of primary ureas: the synthesis of highly substituted imidazolones and imidazoles from diazocarbonyls. J Org Chem (2004) 1.09

A chiral chelating diene as a new type of chiral ligand for transition metal catalysts: its preparation and use for the rhodium-catalyzed asymmetric 1,4-addition. J Am Chem Soc (2003) 1.09

Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Pathobiology (2004) 1.08

Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer. Virchows Arch (2005) 1.07

Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme. J Biol Chem (2006) 1.07

18F-fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response. Int J Clin Oncol (2011) 1.07

K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cells. Cancer Res (2009) 1.06

Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach. Int J Oncol (2006) 1.05

Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy. Interact Cardiovasc Thorac Surg (2012) 1.05

CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer. Oncol Rep (2005) 1.05

Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung. Jpn J Clin Oncol (2011) 1.04

Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer. Anticancer Res (2004) 1.04

Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma. Int J Cancer (2004) 1.03

An air-stable P-chiral phosphine ligand for highly enantioselective transition-metal-catalyzed reactions. J Am Chem Soc (2005) 1.02

Extracting protein interactions from text with the unified AkaneRE event extraction system. IEEE/ACM Trans Comput Biol Bioinform (2010) 1.01

DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci (2003) 1.01

A case of esophageal adenocarcinoma arising from the ectopic gastric mucosa in the thoracic esophagus. Rare Tumors (2010) 1.00

Thyroid hormone-upregulated expression of Musashi-1 is specific for progenitor cells of the adult epithelium during amphibian gastrointestinal remodeling. J Cell Sci (2003) 1.00

No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. Oncol Rep (2005) 1.00

Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases. Biochem Biophys Res Commun (2008) 0.99

Generation of a transgenic silkworm that secretes recombinant proteins in the sericin layer of cocoon: production of recombinant human serum albumin. J Biotechnol (2006) 0.98

Halohydrin and oxime derivatives of radicicol: synthesis and antitumor activities. Bioorg Med Chem (2002) 0.98

Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma. Virchows Arch (2002) 0.98

Expression of RHOC is associated with metastasis of gastric carcinomas. Pathobiology (2004) 0.97

Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer. Oncol Rep (2007) 0.97

Neutrophil elastase induces cell proliferation and migration by the release of TGF-alpha, PDGF and VEGF in esophageal cell lines. Oncol Rep (2007) 0.97

Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma. Virchows Arch (2003) 0.96

A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma Assessment of enhancement patterns on dynamics computed tomography before resection. Hepatol Res (2005) 0.94

Shh/BMP-4 signaling pathway is essential for intestinal epithelial development during Xenopus larval-to-adult remodeling. Dev Dyn (2006) 0.94

Promoter methylation of cyclin D2 gene in gastric carcinoma. Int J Oncol (2003) 0.94

Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast. BMC Cancer (2013) 0.93

Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection. Glycobiology (2008) 0.93

DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage. Cancer Sci (2005) 0.93

MPC1001, a new antitumor antibiotic produced by Cladorrhinum sp. J Antibiot (Tokyo) (2004) 0.93

Esophageal reconstruction using the terminal ileum and right colon in esophageal cancer surgery. Surg Today (2011) 0.93

Current and future roles of neoadjuvant chemotherapy in operable breast cancer. Clin Breast Cancer (2005) 0.93

A germline transgenic silkworm that secretes recombinant proteins in the sericin layer of cocoon. Transgenic Res (2007) 0.93

Clinical significance of aggressive hepatectomy for colorectal liver metastasis, evaluated from the HGF/c-Met pathway. Int J Oncol (2010) 0.92

Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells. Cancer (2005) 0.92

Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma. Int J Cancer (2004) 0.92

Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. Clin Cancer Res (2003) 0.91

Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs. Int J Oncol (2003) 0.91

Advanced esophageal cancer with an esophago-bronchial fistula successfully treated by chemoradiotherapy following esophageal bypass surgery: report of a case. Surg Today (2012) 0.91

Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma. Cancer Sci (2009) 0.90

Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report. Breast Cancer (2008) 0.90

A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer. J Cancer Res Clin Oncol (2004) 0.90

FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer. Horm Cancer (2011) 0.90

A false positive for metastatic lymph nodes in the axillary region of a breast cancer patient following mastectomy. Breast Cancer (2009) 0.90

PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2. Mol Pharmacol (2004) 0.90

Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study. Cancer Chemother Pharmacol (2010) 0.90

Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents. Surg Today (2004) 0.89

Selection of a novel drug-response predictor in esophageal cancer: a novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response. Int J Oncol (2008) 0.89

HER2-specific cytotoxic activity of lymphokine-activated killer cells in the presence of trastuzumab. Anticancer Res (2005) 0.89

Overexpression of the orotate phosphoribosyl-transferase gene enhances the effect of 5-fluorouracil on gastric cancer cell lines. Oncology (2007) 0.89

Enhancement of alpha-secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin. J Neurochem (2007) 0.89

Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes. J Leukoc Biol (2008) 0.89

Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes. Int J Cancer (2004) 0.89

Reconstruction method after pancreaticoduodenectomy. Idea to prevent serious complications. JOP (2012) 0.89

A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II). BMC Cancer (2012) 0.88

Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum. Gen Thorac Cardiovasc Surg (2012) 0.88

Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer. J Steroid Biochem Mol Biol (2010) 0.88

Phase I study of docetaxel (TXT) and 5-fluorouracil (5-FU) with concurrent radiotherapy in patients with advanced esophageal cancer. Anticancer Res (2007) 0.88